DiaMedica Therapeutics(DMAC) - 2024 Q2 - Quarterly Results

Exhibit 99.1 DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results Conference Call and Webcast August 8 at 8:00 AM Eastern Time / 7:00 AM Central Time ● Acute Ischemic Stroke (AIS) Phase 2/3 ReMEDy2 Trial Interim Enrollment (n=144) Targeted for Q1 2025 ● Preeclampsia Phase 2 Investigator-sponsored Trial Beginning in Q4 2024 with Proof-of-Concept Results Targeted for First Half 2025 ● Completed $12 Million Private Placement, Extending Cash Runway Into Q3 2026 M ...